Decent Organic Sales Growth Expected for Abbott Laboratories (ABT) in 2026

Abbott Laboratories (NYSE:ABT) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 23, Larry Biegelsen from Wells Fargo maintained an Overweight rating on Abbott Laboratories (NYSE:ABT). However, the analyst lowered the target price on the stock from $146 to $122. Following this, the stock now offers an upside potential of 15% from the current level. Cidara Therapeutics (CDTX) Skyrockets 105% on Merck $9.2-Billion Acquisition Bid Romaset/Shutterstock.com Biege ...